JAFCO Group logo

JAFCO Group

Crunchbase
Pitchbook
Crunchbase

Deals on record

2

Common Fundraising Type

Equity

Rege Nephro Co., Ltd. is a clinical-stage biotech company developing treatments for kidney diseases, including Autosomal Dominant Polycystic Kidney Disease and Chronic Kidney Disease, using technology from Kyoto University's Center for iPS Cell Research and Application.

Series B
$151.4M
10/07/2024
Article

Nanofiber Quantum Technologies is a startup that develops quantum processing units using neutral atoms and photons as qubits, enabling the processing and storage of quantum information while facilitating communication with other quantum processing units.

Equity
$8.5M
09/19/2023
Article